BOC Value: We offer mild processing methods and buffer optimization to ensure high activity retention post-encapsulation
However, research evidence does not support this concern at typical research doses: Multiple long-term animal studies (extending to 2+ years) have not demonstrated increased cancer incidence Research on IGF-1 signalling in cancer cells shows context-dependent effects (some cancer cells proliferate in response, while others actually undergo differentiation or apoptosis) The IGF-1 receptor is found on essentially every cell type, yet selective activation does not consistently promote malignancy That said, individuals with personal or family history of certain cancers (particularly hormone-sensitive cancers like prostate or breast cancer) should approach IGF-1 LR3 with appropriate caution and medical consultation if applicable
Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) represents a contraindication to semaglutide use
Each receptor arm contributes a distinct metabolic effect, and the three signals interact in ways that appear additive or synergistic on weight reduction and hepatic fat clearance
Understanding your condition can help you manage it better
Semaglutide helps to reduce binge eating episodes and reduces hunger cravings while patients on liraglutide or exenatide experienced more hunger during their weight loss treatments